Variable biological activity of thyroid-stimulating hormone
The DOI matches its Crossref record.
Abstract
Thyroid-stimulating hormone (TSH), like the other pituitary glycoprotein hormones, is produced and secreted as a mixture of isoforms, the majority of which represent differences in oligosaccharide structure and possess different bioactivity. When samples are quantified simultaneously by immunometric assay and bioassay, the ratio between bioactivity (B) and immunoreactivity (I) may serve as an index of the overall potency of TSH. Variations of the TSH B/I ratio have been documented in both physiological and pathological conditions associated with alteration of the two most important mechanisms controlling TSH synthesis and secretion, i.e. TRH release and the thyroid hormone feedback system. Major examples of this assumption are the low TSH bioactivity found in samples from patients lacking TRH and thus bearing a hypothalamic hypothyroidism, and the enhanced bioactivity that is invariably found in TSH from patients with thyroid hormone resistance. Moreover, variations of TSH bioactivity have been recorded in normal subjects during the nocturnal TSH surge, in normal fetuses during the last trimester of pregnancy, in patients with primary hypothyroidism and in patients with TSH-secreting pituitary adenoma and non-thyroidal illness. In conclusion, the secretion of TSH molecules with altered bioactivity plays an important pathogenetic role in various thyroid disorders, while in some particular physiological conditions the bioactivity of TSH may vary in order to adjust thyroid hormone secretion to temporary needs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The impaired bioactivity of circulating TSH has been prevalently demonstrated by in vitro bioassays (15), but this phenomenon can also be supported in vivo by the impaired increment of circulating free T4 and/or T3 following the TSH response upon TRH stimulation test (18, 19).”
From The diagnosis and management of central hypothyroidism in 2018 (2019) · cites this paper as [18]
Citations
Cited by
Thyrotropin-Secreting Pituitary Tumors*
BECK-PECCOZ, P., BRUCKER-DAVIS, F., PERSANI, L., SMALLRIDGE, R. C., & WEINTRAUB, B. D. (1996) · Endocrine Reviews · doi:10.1210/edrv-17-6-610 · Cited by 491
Self-citationSzkudlinski, M. W., Fremont, V., Ronin, C., & Weintraub, B. D. (2002) · Physiological Reviews · doi:10.1152/physrev.00031.2001 · Cited by 458
Brücker-Davis, F., Oldfield, E. H., Skarulis, M. C., Doppman, J. L., & Weintraub, B. D. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.2.476 · Cited by 311
“5 (8) Length of symptoms (yr) 9 6 2 6 6 2 12 6 3 Range 0–26 0–15 2–26 Thyrotoxicosis (n) (25) (14) (11) Absent % 12 21 0 Mild % 32 36 27 Severe % 56 43 73 (123)I 24-h uptake (%) 36 6 6 39 6 8 29 6 13 Goiter %(n) 80 (25) 79 (14) 82 (11) Thyroid nodule %(n) 64 (22) 77 (13) 44 (9) Headaches %(n) 39 (23) 36 (14) 44 (9) Vi…”
BackgroundCentral Hypothyroidism: Pathogenic, Diagnostic, and Therapeutic Challenges
Persani, L. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1616 · Cited by 295
Self-citationVan den Berghe, G., de Zegher, F., Baxter, R. C., Veldhuis, J. D., Wouters, P., Schetz, M., Verwaest, C., Van der Vorst, E., Lauwers, P., Bouillon, R., et al. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.2.4575 · Cited by 204
“TRH resistance (39), or an increased suppressive tone on the thyrotropes, e.”
BackgroundFeldt-Rasmussen, U., Effraimidis, G., & Klose, M. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111173 · Cited by 170
Grossmann, M., Weintraub, B. D., & Szkudlinski, M. W. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.4.0305 · Cited by 160
Central hypothyroidism — a neglected thyroid disorder
Beck-Peccoz, P., Rodari, G., Giavoli, C., & Lania, A. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.47 · Cited by 140
Self-citationCirculating Thyrotropin Bioactivity in Sporadic Central Hypothyroidism
Persani, L. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.10.3631 · Cited by 70
Self-citationThyrotropin-secreting pituitary adenomas: epidemiology, diagnosis, and management
Amlashi, F. G., & Tritos, N. A. (2016) · Endocrine · doi:10.1007/s12020-016-0863-3 · Cited by 117
“activity of TSH as a consequence of altered glycosylation of the TSH molecule [19, 20].”
BackgroundDifferent responses to chronic somatostatin analogues in patients with central hyperthyroidism
Mannavola, D., Persani, L., Vannucchi, G., Zanardelli, M., Fugazzola, L., Verga, U., Facchetti, M., & Beck‐Peccoz, P. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02192.x · Cited by 104
Self-citationPersani, L., Borgato, S., Romoli, R., Asteria, C., Pizzocaro, A., & Beck-Peccoz, P. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.7.4970 · Cited by 85
“The results obtained in adult RTH patients extend previous data (25) and confirm that this syndrome is associated with the secretion of TSH isoforms with altered carbohydrate chains and increased bioactivity, thus explaining the presence of goiter and thyroid hypersecretion despite normal TSH-I levels ( 3 , 25).”
BackgroundResultSelf-citationThyrotropin-secreting pituitary adenomas
Beck‐Peccoz, P., Persani, L., Mantovani, S., CORTELAZZI, D., & Asteria, C. (1996) · Metabolism · doi:10.1016/s0026-0495(96)90089-x · Cited by 89
“…are heterogeneous and may have either a normal, reduced, or increased ratio between their biological and immunological activities, probably due to modification of glycosylation processes secondary to alterations of the post-translational processing of the hormone within the tumor cell (171,172).”
Self-citationHypothalamic thyrotropin-releasing hormone and thyrotropin biological activity
PERSANI, L. (1998) · Thyroid · doi:10.1089/thy.1998.8.941 · Cited by 87
Lania, A., Persani, L., & Beck-Peccoz, P. (2008) · Pituitary · doi:10.1007/s11102-008-0122-6 · Cited by 85
“This quantitative defect in TSH producing cells is associated with a qualitative defect in the secreted TSH isoforms, that conserve immunoreactivity but display a severe impairment in intrinsic biological activity and ability to stimulate thyroid TSH receptors [3, 4].”
BackgroundKienitz, T., Quinkler, M., Strasburger, C. J., & Ventz, M. (2007) · European Journal of Endocrinology · doi:10.1530/eje-07-0098 · Cited by 85
“Baseline TSH levels are not reliable diagnostic markers for TSH-oma since neoplasm-derivedTSH shows a higher bioactivity( 11 ).Thismayexplainconditionsinwhichfree T3 and T4 are elevated, while TSH levels remain normal.”
BackgroundDIAGNOSIS OF ENDOCRINE DISEASE: Diagnostic approach to TSH-producing pituitary adenoma
Tjörnstrand, A., & Nyström, H. F. (2017) · European Journal of Endocrinology · doi:10.1530/eje-16-1029 · Cited by 86
Stockigt, J. R., & Lim, C.-F. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2009.06.004 · Cited by 79
Chatterjee, K. (2009) · Hormone Research · doi:10.1159/000191312 · Cited by 80
The Association Between Prolactin and Metabolic Parameters in PCOS Women: A Retrospective Analysis
Yang, H., Di, J., Pan, J., Yu, R., Teng, Y., Cai, Z., & Deng, X. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00263 · Cited by 91
“TRH can not only promote the release of TSH, but also promote the release of PRL (62, 63).”
BackgroundPersani, L. (1995) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.9.2722 · Cited by 71
Self-citationThe diagnosis and management of central hypothyroidism in 2018
Persani, L., Cangiano, B., & Bonomi, M. (2019) · Endocrine Connections · doi:10.1530/ec-18-0515 · Cited by 64
Self-citationThyrotropin Isoforms: Implications for Thyrotropin Analysis and Clinical Practice
Estrada, J. M., Soldin, D., Buckey, T. M., Burman, K. D., & Soldin, O. P. (2014) · Thyroid® · doi:10.1089/thy.2013.0119 · Cited by 64
“This potential discordance should also be considered when routine TSH immunoassay values are not congruent to FT4 and T3 and/or the clinical circumstance (14,122).”
BackgroundPlasma thyrotropin bioactivity in Down's syndrome children with subclinical hypothyroidism
Konings, C., van Trotsenburg, A., Ris-Stalpers, C., Vulsma, T., Wiedijk, B., & de Vijlder, J. (2001) · European Journal of Endocrinology · doi:10.1530/eje.0.1440001 · Cited by 62
Bertholon-Gregoire, M., Trouillas, J., Guigard, M., Loras, B., & Tourniaire, J. (1999) · European Journal of Endocrinology · doi:10.1530/eje.0.1400519 · Cited by 60
“Thus the bioactivity/immunoreactivity ratio of the released TSH may be normal, reduced ( 17 , 18) or even increased (19), while the intratumor TSH resembles that in a normal pituitary (16).”
BackgroundPituitary Physiology and Diagnostic Evaluation
Melmed, S. K., Kleinberg, D. L., & Ho, K. K. Y. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00008-0 · Cited by 64
Asteria, C., Oliveira, J., Abucham, J., & Beck‐Peccoz, P. (2000) · European Journal of Endocrinology · doi:10.1530/eje.0.1430347 · Cited by 56
Self-citationOliveira, J. H. A., Persani, L., Beck-Peccoz, P., & Abucham, J. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.4.7373 · Cited by 50
“TSH isoforms have been shown to possess different biological activities, and both increased and decreased TSH bioactivities have been reported in several thyroid disorders ( 8 , 9). In central hypothyroidism due to various hypothalamic-pituitary conditions, serum immunoreactive TSH is usually normal or slightly increa…”
BackgroundSelf-citationThyrotropin-releasing hormone stimulation test in patients with pituitary pathology
Hartoft-Nielsen, M.-L., Lange, M., Rasmussen, Å. K., Scherer, S., Zimmermann-Belsing, T., & Feldt-Rasmussen, U. (2004) · Hormone Research in Paediatrics · doi:10.1159/000075239 · Cited by 47
“In fact the finding of slightly elevated TSH in the presence of low free thyroxine (fT 4 ) values and signs or symptoms of hypothyroidism in patients with hypothalamic-pituitary lesions and a normal response to exogenous TSH strongly suggests the secretion of TSH with reduced bioactivity [”
BackgroundCentral hypothyroidism and its role for cardiovascular risk factors in hypopituitary patients
Feldt-Rasmussen, U., & Klose, M. (2016) · Endocrine · doi:10.1007/s12020-016-1047-x · Cited by 43
Nonrandom tissue distribution of mutant mtDNA
Chinnery, P. F., Zwijnenburg, P. J. G., Walker, M., Howell, N., Taylor, R. W., Lightowlers, R. N., Bindoff, L., & Turnbull, D. M. (1999) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19990827)85:5<498::aid-ajmg13>3.0.co;2-8 · Cited by 108
Self-citationDo we still need the TRH stimulation test?
Atmaca, H., Tanriverdi, F., Gokce, C., Unluhizarci, K., & Kelestimur, F. (2007) · Thyroid · doi:10.1089/thy.2006.0311 · Cited by 40
“Basal TSH values may be normal or even mildly elevated in patients with Sheehan’s syndrome which is explained by the presence of TSH isoforms, especially secondary to differences in oligosaccharide content, which have variable bioactivity (2,10).”
García, S. I., Alvarez, A. L., Porto, P. I., Garfunkel, V. M., Finkielman, S., & Pirola, C. J. (2001) · Hypertension · doi:10.1161/01.hyp.37.2.365 · Cited by 40
Pituitary Physiology and Diagnostic Evaluation
Kaiser, U. B., & Ho, K. K. Y. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00008-3 · Cited by 49
Gasparoni, P., Rubello, D., Persani, L., & Beck‐Peccoz, P. (1998) · Thyroid · doi:10.1089/thy.1998.8.181 · Cited by 36
“These tumors cause variable degrees of hyperthyroidism, at least in part due to different biological activity of secreted TSH molecules (5).”
Self-citationCentral hypothyroidism in adults: better understanding for better care
Grunenwald, S., & Caron, P. (2015) · Pituitary · doi:10.1007/s11102-014-0559-8 · Cited by 35
“In qualitative defects due to altered glycosylation of the TSH molecule, the ability to stimulate the TSH receptors of follicular cells is decreased [9–11], although the TSH molecule remains immunereactive which leads to the secretion of a TSH molecule with a decreased biological to immunological ratio.”
BackgroundPhysiology of the Hypothalamic-Pituitary-Thyroid Axis
Mariotti, S., & Beck-Peccoz, P. (2016) · Cited by 49
Self-citationEmerson, C. H., & Torres, M. (2003) · BioDrugs · doi:10.2165/00063030-200317010-00003 · Cited by 40
Structure-function studies of human TSH
Szkudlinski, M. W., Grossmann, M., & Weintraub, B. D. (1996) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(96)00129-4 · Cited by 32
Roelfsema, F., Pereira, A. M., Keenan, D. M., Veldhuis, J. D., & Romijn, J. A. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1145 · Cited by 31
“This observation has been explained by the increased biological activity of TSH by changed glycosylation of the TSH molecule ( 33 ).”
BackgroundYamakita, N. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.3.1054 · Cited by 32
Changes in metabolism of TRH in euthyroid sick syndrome
Duntas, L. H., Nguyen, T., Keck, F. S., Nelson, D., & Iii, J. (1999) · European Journal of Endocrinology · doi:10.1530/eje.0.1410337 · Cited by 28
“One could hypothesize a partial TRH resistance induced by the illness, as has been reported in a study using TRH infusions, but it seems rather improbable, as our patients were in acute phases of disease ( 19 ).”
ResultCentral Nervous System Control of Thyrotropin Secretion during Sleep and Wakefulness
Behrends, J., Prank, K., Dogu, E., & Brabant, G. (1998) · Hormone Research in Paediatrics · doi:10.1159/000023167 · Cited by 27
“in in vitro studies where the messenger RNA (mRNA) expression of TSH-α, -β and prolactin critically depends on the frequency of TSH-releasing hormone (TRH) pulses. Thus, the temporal pattern of secretion appears to be important for the regulation of TSH synthesis. Moreover, the temporal pattern of secretion may reflec…”
MethodRamos, H. E., Labedan, I., Carré, A., Castanet, M., Guemas, I., Tron, E., Madhi, F., Delacourt, C., Maciel, R. M. B., & Polak, M. (2010) · Thyroid · doi:10.1089/thy.2009.0462 · Cited by 27
“Mutations in the TSH b -sub- unit may thus result in an immunoreactive TSH molecule that lacks bioactivity (15).”
Beck-Peccoz, P., Lania, A. G., & Persani, L. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00015-9 · Cited by 34
Self-citationLong-Standing Goiter and Hypothyroidism: An Unusual Presentation of a TSH-Secreting Adenoma
LANGLOIS, M.-F., LAMARCHE, J. B., & BELLABARBA, D. (1996) · Thyroid · doi:10.1089/thy.1996.6.329 · Cited by 26
“The presence of goiter with a normal TSH is not an unusual finding and it is due to an enhanced bioactivity of the hormone (20).”
Lee, K.-O., Persani, L., Tan, M., Sundram, F. X., & Beck-Peccoz, P. (1995) · Journal of Endocrinological Investigation · doi:10.1007/bf03349814 · Cited by 25
Self-citationSerum Thyrotropin Concentrations and Bioactivity During Sleep Deprivation in Depression
Orth, D. N., Shelton, R. C., Nicholson, W. E., Beck‐Peccoz, P., Tomarken, A. J., Persani, L., & Loosen, P. T. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.1.77 · Cited by 25
“Increased thyrotropinbioactivity, causedbydecreased terminal sialic acid residues on thyrotropin carbohydrate side chains, occurs in healthy third-trimester human fetuses and patients with thyroid hormone resistance.(64,65) Decreased bioactivity caused by increased sialylation is found at night in healthy subjects and…”
BackgroundSelf-citationTreatment of central hypothyroidism*: Commentary
Beck-Peccoz, P. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04037.x · Cited by 23
Self-citationDiscoveries Around the Hypothalamic–Pituitary–Thyroid Axis
Hershman, J. M., & Beck-Peccoz, P. (2023) · Thyroid · doi:10.1089/thy.2022.0258 · Cited by 31
“56 Studies on TSH molecular structure and biological activity have led to the synthesis of small molecules with either antagonist or superagonist activity on the TSH receptor.”
Self-citationMansourian, A. R. (2011) · Pakistan Journal of Biological Sciences · doi:10.3923/pjbs.2011.313.326 · Cited by 27
Syndromes of thyroid hormone resistance
Beck‐Peccoz, P., Mannavola, D., & Persani, L. (2005) · Annales d Endocrinologie · doi:10.1016/s0003-4266(05)81760-3 · Cited by 18
“Modifications of TSH glycosylated chains seem to account for the above finding [5].”
ResultSelf-citationTakamizawa, T., Horiguchi, K., Nakajima, Y., Okamura, T., Ishida, E., Matsumoto, S., Yoshino, S., Yamada, E., Saitoh, T., Ozawa, A., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00466 · Cited by 20
TSH-induced hyperthyroidism caused by a pituitary tumor
Beck-Peccoz, P., & Persani, L. (2006) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0276 · Cited by 16
Self-citationPituitary-Thyroid Setpoint and Thyrotropin Receptor Expression in Consomic Rats
Moeller, L. C., Alonso‐Sampedro, M., Liao, X.-H., Broach, V. A., Dumitrescu, A. M., SANDE, J. V., Montanelli, L., Skjei, S., Goodwin, C., Grasberger, H., et al. (2007) · Endocrinology · doi:10.1210/en.2007-0236 · Cited by 16
Maccagnan, P., Oliveira, J. H. A., Castro, V., & Abucham, J. (1999) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1999.00808.x · Cited by 16
Wei, G., Zhang, C.-X., Yu, J., Chen, X., Song, H., & Yang, L. (2022) · Chemosphere · doi:10.1016/j.chemosphere.2022.136354 · Cited by 19
Pituitary-hormone secretion by thyrotropinomas
Roelfsema, F., Kok, S. W., Kok, P., Pereira, A. M., Biermasz, N. R., Smit, J. W. A., Frölich, M., Keenan, D. M., Veldhuis, J. D., & Romijn, J. A. (2008) · Pituitary · doi:10.1007/s11102-008-0159-6 · Cited by 17
“This observation has been explained by increased biological activity of less acidic post-glycosylation isoforms of TSH [32].”
BackgroundHerguido, N. G., Fuentes, E. D., Venegas-Moreno, E. M., Borau-Maorad, L., Flores‐Martínez, Á., Remón-Ruiz, P., Dueñas, M. C., Roldán, F., Fajardo, E., Ruiz‐Valdepeñas, E. C., et al. (2019) · World Neurosurgery · doi:10.1016/j.wneu.2019.06.180 · Cited by 15
Diagnosis and Management of Iatrogenic Hypothyroidism
Peterson, M. E. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-22652-3.00023-2 · Cited by 16
Thyrotropin-Secreting Pituitary Adenomas
Beck‐Peccoz, P., & Persani, L. (2002) · Endocrine updates · doi:10.1007/978-1-4615-1115-1_8 · Cited by 15
Self-citationTransiently Decreased Sialylation of Thyrotropin (TSH) in a Patient with the Euthyroid Sick Syndrome
Magner, J. A., Roy, P. K., Fainter, L. K., Barnard, V., & Fletcher, P. L. (1997) · Thyroid · doi:10.1089/thy.1997.7.55 · Cited by 14
“…are very low (suggesting that TSH at that time might have increased bioactivity) (11-13), while at another stage of the illness the serum T4 and T3 levels do not rise rapidly in spite of a readily detectable level of TSH (suggesting that TSH at that time might have reduced bioactivity) (11,14).”
InfluentialBorgato, S., Persani, L., Romoli, R., CORTELAZZI, D., Spada, A., & Beck‐Peccoz, P. (1998) · Journal of Endocrinological Investigation · doi:10.1007/bf03350773 · Cited by 14
Self-citationTSH Levels in Subclinical Hypothyroidism in the 97.5th Percentile of the Population
Mayoral, L. P.-C., Hernández‐Huerta, M. T., Andrade, G. M., Mayoral, E. P., Zenteno, E., Martínez-Cruz, R., Ruiz, H. M., Cruz, M. M., Pérez-Santiago, A. D., & Pérez‐Campos, E. (2020) · International Journal of Endocrinology · doi:10.1155/2020/2698627 · Cited by 16
“)erefore, these authors suggest the evaluation of bioactive TSH, in particular, the ratio between bioactivity (B) and immunoreactivity (I), B/I can be useful [33].”
BackgroundАстафьева, Л. И., Кадашев, Б. А., Shishkina, L. V., Kalinin, P. L., Fomichev, D. V., Kutin, M. A., Aref'eva, I. A., Dzeranova, L. K., Sidneva, Y., Klochkova, I. S., et al. (2016) · Burdenko s Journal of Neurosurgery · doi:10.17116/neiro201680624-35 · Cited by 13
Thyrotropin-secreting Pituitary Adenomas
Zemskova, M., & Skarulis, M. C. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-264-9_13 · Cited by 10
Woodmansee, W. W. (2013) · Wiley eBooks · doi:10.1002/9781118559406.ch16 · Cited by 10
Thyrotropin-Secreting Pituitary Tumors
Rouach, V., & Greenman, Y. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-380926-1.10017-3 · Cited by 9
Buchfelder, M. (2002) · The Endocrinologist · doi:10.1097/00019616-200203000-00010 · Cited by 8
“Immunoreactive TSH synthesized from a thyrotroph adenoma when partially purified by immunoaffinity chromatography showed a higher activity in stimulating adenylate cyclase from a human thyroid membrane preparation than normal TSH [18, 19].”
BackgroundBeck-Peccoz, P., & Persani, L. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00017-4 · Cited by 13
Self-citationClinical uses of recombinant human thyrotropin
Gourgiotis, L., & Skarulis, M. C. (2004) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.5.12.2503 · Cited by 7
“The oligosaccharide structures influence the clearance and the bioactivity of the hormone [4,5].”
BackgroundLong term treatment of a thyrotropin-secreting microadenoma with somatostatin analogues
Tenreiro, A. M. P., & Díaz-Guardiola, P. (2010) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302010000500012 · Cited by 4
Physiology of the Hypothalamic-Pituitary Thyroidal System.
Mariotti, S. (2011) · UNICA IRIS Institutional Research Information System (University of Cagliari) · Cited by 8
Collins, M. T., Remaley, A. T., Csákó, G., Pucino, F., Skarulis, M. C., Balow, J. E., & Sarlis, N. J. (2000) · Journal of Endocrinological Investigation · doi:10.1007/bf03343742 · Cited by 6
Uncertainties in endocrine substitution therapy for central endocrine insufficiencies
Persani, L., & Bonomi, M. (2014) · Handbook of clinical neurology · doi:10.1016/b978-0-444-59602-4.00027-7 · Cited by 6
Self-citationFröhlich, E., & Wahl, R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411699 · Cited by 5
Hypothalamic-Pituitary-Thyroid Axis in Aging
Samuels, M. H., Pekary, A. E., & Hershman, J. M. (2000) · Humana Press eBooks · doi:10.1007/978-1-59259-715-4_4 · Cited by 4
Clinical Implication of Serum TSH Concentration
Cho, Y.-W. (2007) · Journal of Korean Endocrine Society · doi:10.3803/jkes.2007.22.2.87 · Cited by 4
“시상하부-뇌하수 체 기능저하증에서는 생물학적 활성도가 감소된 TSH가 분 비되고[30~32], 1차성 갑상선기능저하증, 갑상선 호르몬저 항증, 일부의 TSH 분비종양 등에서는 분비되는 TSH의 생 물학적 활성도가 높다[60,61].”
Thyroid-Stimulating Hormone-Mediated Hyperthyroidism
Magner, J. A. (2004) · The Endocrinologist · doi:10.1097/01.ten.0000134749.81648.c5 · Cited by 4
Tumores hipofisários secretores de TSH: relato de dois casos e revisão da literatura
Duarte, F. H. G., Jallad, R. S., Salgado, L. R., & Bronstein, M. D. (2009) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302009000900013 · Cited by 4
Is It Time to Expand Newborn Screening for Congenital Hypothyroidism to Other Rare Thyroid Diseases?
Olivieri, A., Vigone, M. C., Salerno, M., & Persani, L. (2025) · International Journal of Neonatal Screening · doi:10.3390/ijns11030065 · Cited by 4
Self-citationBuchfelder, M., & Fahlbusch, R. (2001) · Humana Press eBooks · doi:10.1385/1-59259-217-1:333 · Cited by 5
Successful resection of TSH-secreting pituitary adenoma demonstrated by serial 99mTc-scintigraphy
Brandstätter, W., Hatzl, M., Weis, S., Jávor, A., & Gabriel, M. (2015) · Nuklearmedizin - NuclearMedicine · doi:10.1055/s-0037-1616611 · Cited by 2
“Thus, baseline TSH-levels are not a reliable diagnostic marker (2).”
BackgroundShould the TSH test be utilized in the diagnostic confirmation of suspected hypothyroidism?
Wheatland, R. (2010) · Medical Hypotheses · doi:10.1016/j.mehy.2010.04.024 · Cited by 2
“Current TSH immunoassays measure the concentration of TSH without regard to the relative bioactivity of the isoforms [29].”
BackgroundThyroid Function Tests and the Effects of Drugs
Feldt‐Rasmussen, U. (2022) · doi:10.1093/med/9780198870197.003.0041 · Cited by 3
EVALUATION OF THE PATIENT WITH A SUSPECTED THYROID DISORDER
Bryer‐Ash, M. (2001) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/s0889-8545(05)70209-6 · Cited by 2
Feldt‐Rasmussen, U., Klose, M., & Rasmussen, Å. K. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.96006-9 · Cited by 2
Geremia, C., & Geremia, F. (2025) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2025-0082 · Cited by 1
Disorders of the Hypothalamic–Pituitary–Thyroid Axis
Sidhaye, A. R., & Wondisford, F. E. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-375097-6.10031-9 · Cited by 1
Evaluation of Thyroid Profile and Complement ‘C3’ in Metabolic Syndrome
Shaker, I. A., Suritha, P. K., Sheth, N. D., & Sailaja, I. (2019) · Indian Journal of Medical Biochemistry · doi:10.5005/jp-journals-10054-0085 · Cited by 1
Sidhaye, A. R. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-4745-2.00018-3 · Cited by 1
Causes and laboratory investigation of hypothyroidism
Santini, F., & Pinchera, A. (2011) · doi:10.1093/med/9780199235292.003.3243 · Cited by 1
Clinical thyroidology: beyond the 1970s’ TSH-T4 Paradigm
Lindner, H. H. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1529791 · Cited by 2
Thyroid function tests and the effects of drugs
Stockigt, J. (2011) · doi:10.1093/med/9780199235292.003.3031 · Cited by 2
Physiopathology, Diagnosis, and Treatment of Secondary Hyperthyroidism
Beck-Peccoz, P., Giavoli, C., Rodari, G., & Lania, A. G. (2018) · Endocrinology · doi:10.1007/978-3-319-44444-4_8 · Cited by 1
Self-citationUpdate on the Sick Euthyroid Syndrome
Stockigt, J. R. (1997) · doi:10.1007/978-1-4757-2594-0_4 · Cited by 1
Safer, J. D. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-352-1_10
Ipotiroidismo centrale: diagnosi, patogenesi e terapia sostitutiva
Persani, L., Ferretti, E., Giavoli, C., & Bonomi, M. (2005) · L Endocrinologo · doi:10.1007/bf03345936
Self-citationCano‐Corres, R., Ramírez, A. A., Álvarez, J. S., Ramos, P. A., & Padró‐Miquel, A. (2011) · Revista del Laboratorio Clínico · doi:10.1016/j.labcli.2011.01.002
Chapter 13b – THYROTROPIN-SECRETING PITUITARY ADENOMAS
Beck-Peccoz, P., & Endocrinology, P. O. (2013)
Self-citation
Metadata
- Authors
- Beck-Peccoz, P., & Persani, L.
- Affiliations
- University of Milan (IT)
- ORCID
- Persani, Luca
- Venue
- European Journal of Endocrinology
- Publisher
- Oxford University Press (OUP)
- Published
- 1994-10
- Volume
- 131
- Issue
- 4
- Pages
- 331-340
- ISSN
- 0804-4643 (ISSN-L)
- 1479-683X
- OpenAlex
- W2029647014
- Cited by
- 116
- References
- 0
- Citations by year
- 2026: 2 · 2025: 3 · 2023: 4 · 2022: 2 · 2021: 1 · 2020: 2 · 2019: 5 · 2018: 1 · 2017: 5 · 2016: 5 · 2015: 3 · 2014: 3 · 2013: 4 · 2012: 2
- FWCI
- 2.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Journal of Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
- Keywords
- thyroid-stimulating hormone, TSH receptor, thyrotropin-releasing hormone, thyroid hormone feedback, hypothalamic hypothyroidism, thyroid hormone resistance, pregnancy, primary hypothyroidism, TSH-secreting pituitary adenoma, low T3 syndrome
- MeSH terms
- Animals, Humans, Isomerism, Thyroid Diseases, Thyrotropin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.